Melhores podcasts sobre Sandra Patel (2024)

1
Adrianto Wirawan: What does 'no primary findings' mean? 3:57

23h ago3:57

3:57

In this explainer episode, we’ve asked Adrianto Wirawan, Director of Bioinformatics Engineering at Genomics England, to explain what the term 'no primary findings' means. You can also find a series of short videos explaining some of the common terms you might encounter about genomics on our YouTube channel. If you’ve got any questions, or have any …

1
Mathilde Leblond: What do parents want to know about the Generation Study? 11:07

8d ago11:07

11:07

In this explainer episode, we’ve asked Mathilde Leblond, Senior Design Researcher for the Generation Study at Genomics England, to answer some frequently asked questions that we received from parents who we engaged with for the design of the study. You can hear more information about Generation Study via the study's official website and in our prev…

1
The Power of Quality Interactions: A Conversation with Rux Dariescu 38:09

10d ago38:09

38:09

In this episode of "Let's Talk Leadership," we dive deep into the critical role of quality interactions within business settings. Rux Dariescu, an experienced coach and expert in leadership development, shares her journey and insights on how meaningful and effective communication can transform organisational success. We explore the definition of a …

1
Callum Morris: What happens in a clinical trial? 8:26

15d ago8:26

8:26

In this explainer episode, we’ve asked Callum Morris, Pharmaceutical Research and Development Insights Manager at Genomics England, to explain what happens in a clinical trial. You can also find a series of short videos explaining some of the common terms you might encounter about genomics on our YouTube channel. If you’ve got any questions, or hav…

1
Nicole Chai: How does X-linked inheritance work? 3:25

22d ago3:25

3:25

In this explainer episode, we’ve asked Nicole Chai, Research and Development Bioinformatician at Genomics England, to explain what X-linked inheritance is. You can also find a series of short videos explaining some of the common terms you might encounter about genomics on our YouTube channel. If you’ve got any questions, or have any other topics yo…

1
Arina Puzriakova: What is a polygenic disorder? 5:50

29d ago5:50

5:50

In this explainer episode, we’ve asked Arina Puzriakova, Scientific Curator at Genomics England, to explain what a polygenic disorder is. You can also find a series of short videos explaining some of the common terms you might encounter about genomics on our YouTube channel. If you’ve got any questions, or have any other topics you’d like us to exp…

1
Öznur Özkurt, Mathilde Leblond, Rebecca Middleton and Sandra Igwe: How has design research shaped the Generation Study? 24:02

1M ago24:02

24:02

The Generation Study is a research initiative aiming to explore the use of whole genome sequencing in newborns, to screen for more than 200 rare genetic conditions. This study will recruit 100,000 babies across England, and you can learn more about the Generation Study via the study's official website. Design research has played a vital role in sha…

1
Amanda Pichini: Which healthcare professionals are involved in my genomic healthcare journey? 5:33

1M ago5:33

5:33

In this explainer episode, we’ve asked Amanda Pichini, Clinical Director at Genomics England and Genetic Counsellor, to explain which healthcare professionals you may come into contact with in your genomic healthcare journey. You can also find a series of short videos explaining some of the common terms you might encounter about genomics on our You…

1
Navigating Growth: Leadership lessons from Peyman Pouryekta 33:20

1M ago33:20

33:20

In this episode of Let’s Talk Leadership, we sit down with Peyman Pouryekta, Founder & Managing Director of a dynamic advisory business offering IT strategy, talent strategy, product management, brand management, and much more. Join us as Peyman shares his inspiring journey from humble beginnings to becoming a prominent leader in the tech industry.…

1
Maili Raven-Adams, Niharika Batra, Trupti Patel and Naimah Callachand: How can we ensure equitable access to genomic medicine? 37:11

2M ago37:11

37:11

Digital consent models, language barriers, and cultural differences are just a few factors that can exclude people from participating in genomic research. In this episode, our guests discuss these issues, and explore alternative methods such as in-person discussions and the use of trusted community figures to engage with their communities to increa…

1
Rising from the Ground Up: Brittney Harrell on Leadership; DE&I, and navigating the Tech Industry. 35:11

2M ago35:11

35:11

In this episode of Let’s Talk Leadership, we sit down with Brittney Harrell, Head of Information Security and a passionate DE&I advocate at Nabla, a leading AI company focused on enhancing healthcare by reducing practitioner stress. Join us as Brittney shares her inspiring journey from humble beginnings to becoming a prominent leader in the tech in…

1
Natasha Gordon-Douglas, Oleander Agbetu, Jayson Kupoluyi and Marie Nugent: How can organisations support those living with sickle cell? 43:42

2M ago43:42

43:42

For Sickle Cell Awareness Month, our sickle cell Patient Voice Group discuss their lived experiences with sickle cell, shedding light on how organisations need to be considerate when engaging with patients. They emphasise the need for genuine engagement and transparency from researchers, while highlighting the importance of building trust within co…

1
Aman Ali, Anna Smith, Moestak Hussein and Naimah Callachand: How can we bridge the gap between diverse communities? 36:45

3M ago36:45

36:45

In this episode of Behind the Genes, we explore the challenges diverse communities face in accessing genomic medicine. The discussion focuses on issues including language barriers, cultural differences, and socioeconomic disparities that hinder marginalised communities from accessing and benefitting from genomic medicine. Our guests delve into succ…

1
Vivienne Parry, Professor Bill Newman, Anita Hanson and Professor Matt Brown: Can genomic testing prevent adverse drug reactions? 36:49

3M ago36:49

36:49

Pharmacogenomics plays a critical role in personalised medicine, as some adverse drug reactions are genetically determined. Adverse drugs reactions (ADRs) account for 6.5% of hospital admissions in the UK, and the application of pharmacogenomics to look at an individuals response to drugs can significantly enhance patient outcomes and safety. In th…

1
Sarah Wynn, Emma Baple, Lindsay Pearse and Naimah Callachand: How has a groundbreaking genomic discovery impacted thousands worldwide? 38:08

4M ago38:08

38:08

In this episode, we delve into the impact of the new groundbreaking research uncovering the RNU4-2 genetic variant linked to neurodevelopmental conditions. The discovery, made possible through whole genome sequencing, highlights a genetic change in the RNU4-2 gene that affects about 1 in 200 undiagnosed children with neurodevelopmental conditions, …

1
Dr Rich Scott and Helen White: How can we work in partnership towards a new era of genomic medicine and research? 44:56

4M ago44:56

44:56

Genomics has changed considerably over the past 10 years, and we are now exploring how to integrate it into routine healthcare. In this episode, our guests reflect on this evolution and discuss how the key learnings from the past 10 years can shape the genomics ecosystem of the future. They highlight the importance of partnership across teams, orga…

1
James Duboff: Genomics 101 - How do pharmaceutical companies use genomic data for drug discovery? 13:10

6M ago13:10

13:10

In this explainer episode, we’ve asked James Duboff, Strategic Partnerships Director at Genomics England, to explain how genomic data can be used in drug discovery. You can also find a series of short videos explaining some of the common terms you might encounter about genomics on our YouTube channel. If you’ve got any questions, or have any other …

1
Professor Sir Jonathan Montgomery, Dr Latha Chandramouli and Dr Natalie Banner: Why do we need to consider ethics in genomic healthcare and research? 42:41

6M ago42:41

42:41

Ethical considerations are essential in genomic medicine and clinical practice. In this episode, our guests dive into the details of ethical principles, highlighting how they can be brought into practice in the clinic, whilst considering the experiences and feelings of patients and participants. Our host, Dr Natalie Banner, Director of Ethics at Ge…

1
Professor Matt Brown: Genomics 101 - What is personalised medicine? 4:27

6M ago4:27

4:27

In this explainer episode, we’ve asked Professor Matt Brown, Chief Scientific Officer at Genomics England, to explain what personalised medicine is and how it could change the way we treat genetic conditions and cancer. You can also find a series of short videos explaining some of the common terms you might encounter about genomics on our YouTube c…

1
Will Navaie: Genomics 101 - What is 'ethics'? 7:14

7M ago7:14

7:14

In this explainer episode, we’ve asked Will Navaie, Head of Ethics Operations at Genomics England, to explain what ethics is and why it's important, in the context of genomics. You can also find a series of short videos explaining some of the common terms you might encounter about genomics on our YouTube channel. If you’ve got any questions, or hav…

1
Marie Nugent: Genomics 101 - Why is diversity important in genomics research? 8:37

7M ago8:37

8:37

In this explainer episode, we’ve asked Marie Nugent, Community Manager for the Diverse Data Initiative at Genomics England, to explain what diversity is and why it's important, in the context of genomics. You can also find a series of short videos explaining some of the common terms you might encounter about genomics on our YouTube channel. If you’…

1
Ellen Thomas: Genomics 101 - What is genetic or genomic testing? 5:23

7M ago5:23

5:23

In this explainer episode, we’ve asked Ellen Thomas, Interim Chief Medical Officer at Genomics England, to explain what genetic and genomic tests are, why someone might do a test, and how they are performed, in less than 10 minutes. You can also find a series of short videos explaining some of the common terms you might encounter about genomics on …

1
Shaun Pye, Sarah Crawford, Sarah Wynn and Naimah Callachand: Shining a light on rare conditions 42:26

8M ago42:26

42:26

Joey was diagnosed with DYRK1A syndrome at the age of 13, through the 100,000 Genomes Project. DYRK1A syndrome is a rare chromosomal disorder, caused by changes in the DYRK1A gene which causes a degree of developmental delay or learning difficulty. In today's episode, Naimah Callachand, Head of Product Engagement and Growth at Genomics England, spe…

1
Clare Kennedy: Genomics 101 - What is the difference between DNA and RNA? 9:14

8M ago9:14

9:14

In this explainer episode, we’ve asked Clare Kennedy, Clinical Bioinformatician at Genomics England, to explain what the difference is between DNA and RNA, in less than 10 minutes. You can also find a series of short videos explaining some of the common terms you might encounter about genomics on our YouTube channel. If you’ve got any questions, or…

1
Lisa Beaton, Dr Celine Lewis, Jana Gurasashvili and Louise Fish: Hope for those with "no primary findings" 44:12

8M ago44:12

44:12

There are a range of outcomes from a genomic test. The results might provide a diagnosis, there may be a variant of uncertain significance, where a genetic variant is likely the cause of the condition, or there might be no particular gene found that is linked to the phenotype or clinical condition - also known as a "no primary finding" result. In t…

1
Revolutionising the Workplace with AI & Automation 37:25

8M ago37:25

37:25

In this fascinating episode we explore the impact that AI and automation is having on businesses right now. Hosted on Acast. See acast.com/privacy for more information.

1
Helen Brittain: Genomics 101 - What is a variant of uncertain significance? 9:25

8M ago9:25

9:25

In this explainer episode, we’ve asked Helen Brittain, Clinical Lead for Rare Disease Diagnostics at Genomics England, to explain what a variant of uncertain significance is, in less than 10 minutes. You can also find a series of short videos explaining some of the common terms you might encounter about genomics on our YouTube channel. If you’ve go…

1
Julia Vitarello, Rich Scott and Ana Lisa Tavares: Treating Mila - Lessons for those living with rare conditions 45:44

9M ago45:44

45:44

29 February marks Rare Disease Day. This day is an opportunity for the rare community to come together to raise awareness of the common issues affecting those living with rare conditions. A rare condition is a condition that affects less than one in 2,000 in the population, and although rare conditions are individually rare they are collectively co…

1
Facing Imposter Syndrome: Real Stories, Real Solutions 32:14

9M ago32:14

32:14

We speak to the amazing Becky Nicholson, who is a Delivery Director at NEC Software Solutions. With a career spanning across various sectors including telecoms, financial services, gambling and higher education; Becky brings a wealth of experience in management and leadership to the table. Known for her authenticity, pragmatism and transparency, Be…

1
David Bick: Genomics 101 - What is the Generation Study? 6:20

9M ago6:20

6:20

In this explainer episode, we’ve asked David Bick, Principal Clinician for the Newborn Genomes Programme at Genomics England, to explain more about the Generation Study, in less than 10 minutes. For more information you can listen to our podcast episode where David discusses the conditions that we will initially look for in the study. You can also …

1
Vivienne Parry, Louise Fish and Professor Matt Brown: Celebrating genomic breakthroughs - Insights from the Festival of Genomics 36:27

9M ago36:27

36:27

In January we saw experts from across the genomics ecosystem, including patients and those with an interest in genomics, gather at the Festival of Genomics - the UK's largest annual life sciences event. In this episode, our host, Vivienne Parry, Head of Engagement at Genomics England, speaks to Louise Fish, CEO of Genetic Alliance UK, and Professor…

1
Ana Lisa Tavares: Genomics 101 - What is a rare condition? 6:54

9M ago6:54

6:54

In this explainer episode, we’ve asked Ana Lisa Tavares, Clinical Lead for rare disease research at Genomics England, to explain what a rare condition is, in less than 10 minutes. You can also find a series of short videos explaining some of the common terms you might encounter about genomics on our YouTube channel If you’ve got any questions, or h…

1
Dr Natalie Banner, Ismael Kherroubi García and Francisco Azuaje: Can Artificial Intelligence accelerate the impact of genomics? 35:36

10M ago35:36

35:36

On this episode, we delve into the promising advances that artificial intelligence (AI) brings to the world of genomics, exploring its potential to revolutionise patient care. Our guests discuss public perspectives on AI in genomics and address the ethical complexities that arise in this rapidly evolving field. Gain valuable insights into the futur…

1
Navigating Start-Up Challenges & Funding Trends 21:36

10M ago21:36

21:36

In this installment, we're thrilled to have Paul Hallett, CEO and Co-founder of Vet-AI, join us for an insightful conversation. Paul, a seasoned leader in the tech industry, brings a wealth of experience and innovation to the table. As a driving force behind Vet-AI, he's at the forefront of tackling challenges in the veterinary space, addressing is…

1
Dr Nirupa Murugaesu and Professor Sir Mark Caulfield: Providing tailored care for cancer patients through whole genome sequencing 33:39

10M ago33:39

33:39

In this instalment, our guests engage in a compelling discussion centred around a recently published paper that supports the integration of whole genome sequencing into standard cancer care. Our guests shed light on the transformative potential of combining health data with whole genome data. Discover how this innovative approach empowers doctors t…

1
Reducing Employee Attrition, Remote Work & Motivating Your Team to Innovate 29:06

10M ago29:06

29:06

Martin Sabag, VP of Product Management at CurveTech.AI, returns to the podcast! Martin is a seasoned product management leader with over a decade of experience, driving innovation and user-centric solutions at CurveTech.AI, where he specialises in reducing contact center employee attrition through AI and data insights. As a thought leader in produc…

1
Decoding Hybrid: The Impact on Culture, Collaboration & Innovation 34:45

11M ago34:45

34:45

We're joined by Dan Whiteley, Chief Technology Officer of Bede Gaming. Dan is a seasoned technology leader with a rich background in driving innovation, shaping strategy and delivering digital transformation. He joins us for a discussion about the hybrid model. Remote and hybrid work arrangements are incredibly popular in the tech industry. They've…

1
Dr Rich Scott: Reflecting on 2023 - A year of podcasts and a decade of progress 30:07

11M ago30:07

30:07

As we approach the conclusion of 2023, we reflect on a year that not only signifies our 10-year anniversary but also marks another chapter of our podcast. Throughout the year, guests have joined us fortnightly to share their research, stories, and aspirations for the future of genomic healthcare. In this special end-of-year episode, Naimah Callacha…

1
Dr Helen Hanson, Kelly Kohut, Rochelle Gold and Amanda Pichini: How are genetic tests transforming cancer prevention? 37:17

11M ago37:17

37:17

On today's episode, our guests will be discussing the CanGene-CanVar programme. Funded by Cancer Research UK, the 5-year programme aims to create an interface between NHS clinical care and research that will expand genetic testing access for those with inherited cancers. Our host Amanda Pichini, Clinical Lead for Genetic Counselling at Genomics Eng…

1
Rebecca Middleton, Professor Dame Sue Hill and Dr Rich Scott: Transforming the NHS with genomic testing 42:35

12M ago42:35

42:35

This year as we celebrated our 10-year annivesary, the NHS celebrated a significant milestone of 75 years. In this episode we reflect on our journey over the last 10 years, including the impact of embedding genomic testing into the NHS, how it all started with the 100,000 Genomes Project, and how patients have influenced the shape of the Genomic Me…

1
The Ultimate Guide to Start-Up Leadership with "The Tinder of Student Housing" 38:46

12M ago38:46

38:46

"The Tinder of Student Housing"... That's how users and PropTech thought leaders are describing Housr right now! They're ripping-up the rulebook when it comes to property. Having secured over £1.2 million in funding and now expanding into the US, we wanted to find out what makes this start-up so special. In this episode, Sandra speaks to Harry Pant…

1
Amanda Pichini, Jonathan Roberts and Emma Walters: How can Genetic Counsellors improve care through research? 51:02

1y ago51:02

51:02

Genetic Counsellors play an important part in healthcare and research. This Genetic Counsellor Awareness Day we focus on the role genetic counsellors have in research, to help improve care for patients and families. On this episode of the G Word, Amanda Pichini, Clinical Lead for Genetic Counselling at Genomics England, is joined by Emma Walters, m…

1
The Impact of Getting to the C-Suite Early in Your Career 38:13

1y ago38:13

38:13

We're joined by Brad Richards, Chief Product Officer at LOVOO, who shares a very honest reflection on his leadership journey. Join us for a chat about burnout, imposter syndrome and transitioning into the the c-suite. If you'd like to speak to us about the episode or being a future guest, email our editor Dan at dan.wilkinson@transition-partners.co…

1
Dr Mie Rizig, Sir John Hardy, Candice King and Will Townley: Why is diversity in Parkinson’s research so important? 36:22

1y ago36:22

36:22

Unfortunately, please note you may be able to hear some background noise or static during some parts of the recording. In this episode of the G Word, Candice King, Patient and Public Engagement Manager and Will Townley, Cohorts Manager who both work at the Diverse Data initiative at Genomics England, are joined by Dr Mie Rizig and Sir John Hardy, w…

1
Leadership During an Acquisition That Was Completed in Just 4 Weeks 33:31

1y ago33:31

33:31

We're joined by Mark Joyce, CTO Transformation Advisor at Purple Bricks, who shares his remarkable journey of leadership during the acquisition of Purple Bricks. Join us for a thoughtful and sensitive discussion on leadership, resilience and adaptability. If you'd like to speak to us about the episode or being a future guest, email our editor Dan a…

1
Live @Leeds Digital Festival - Adapting to HR & TA Challenges in 2023 27:21

1y ago27:21

27:21

ft. Orlagh Hunt, Yasmin De Nardo & Mark Botham Hosted on Acast. See acast.com/privacy for more information.

1
Vivienne Parry and David Bick: Which conditions will we look for initially in the Generation Study? 25:24

1y ago25:24

25:24

The Newborn Genomes Programme is delivering the Generation Study in partnership with the NHS. The study will explore the possibilities of whole genome sequencing in newborn babies, including to identify a wider range of rare genetic conditions current NHS newborn blood spot test. To do this, we have undertaken significant engagement work to identif…

1
Live @Leeds Digital Festival - Leading Change: Debugging DEI in Tech 1:06:45

1y ago1:06:45

1:06:45

At TP we recently a Leeds Digital Festival event! Our four amazing guest speakers were able to shake-up the conversation around Diversity, Equity, and Inclusion (DEI), addressing the topics often left unsaid in the workplace - such as menopause, miscarriage, neurodiversity, ex-offenders and more. Quick apologies for the background noise / audio qua…

1
Dr Jack Bartram: Can genomics improve our understanding of childhood cancers? 28:26

1y ago28:26

28:26

In this episode of the G Word, Naimah Callachand, Head of Product Engagement and Growth at Genomics England, is joined by Dr Jack Bartram, consultant paediatric haematologist at Great Ormond Street Hospital (GOSH) for Children. Dr Bartram leads on molecular diagnostics within the haematology department at GOSH and has expertise in minimal residual …

1
The Importance of Being People-Centric & Values-Led as a Leader 30:20

1y ago30:20

30:20

We chat with Mo Anoshehpour, the Head of Software Development at Lhasa. Mo shares his journey from starting as a developer to becoming head of the software development team. He discusses the importance of developing your skills and being people-centric, as well as how the company's values have impacted his own leadership style. Mo also shares some …

Podcasts que valem a pena ouvir

Podcasts sobre Sandra Patel

Podcasts que valem a pena ouvir

Guia rápido de referências